Elicio Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
09 Apr 24 | SellUS$927,470 | Clal Biotechnology Industries Ltd. | Company | 117,470 | US$9.44 | |
19 Mar 24 | SellUS$537,524 | Clal Biotechnology Industries Ltd. | Company | 82,696 | US$6.50 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 199,564 | 1.85% |
Institutions | 968,209 | 8.98% |
Individual Insiders | 2,130,034 | 19.8% |
General Public | 7,479,064 | 69.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,915,639 | US$9.3m | -0.24% | no data | |||
416,570 | US$2.0m | 0% | 28.75% | |||
245,262 | US$1.2m | 8.38% | no data | |||
199,564 | US$973.9k | 0% | no data | |||
130,534 | US$637.0k | 0% | no data | |||
71,574 | US$349.3k | 0.09% | no data | |||
50,000 | US$244.0k | 0% | 0.19% | |||
50,000 | US$244.0k | 0% | 0.54% | |||
46,970 | US$229.2k | 0% | no data | |||
31,981 | US$156.1k | 0% | no data | |||
30,769 | US$150.2k | 175% | no data | |||
21,900 | US$106.9k | 0% | no data | |||
19,693 | US$96.1k | 3.73% | no data | |||
13,899 | US$67.8k | 0% | no data | |||
12,856 | US$62.7k | 0% | no data | |||
12,500 | US$61.0k | 0% | no data | |||
9,997 | US$48.8k | 0% | 0.16% | |||
7,000 | US$34.2k | 0% | no data | |||
3,039 | US$14.8k | 0% | no data | |||
1,871 | US$9.1k | 0% | no data | |||
1,554 | US$7.6k | 0% | no data | |||
1,146 | US$5.6k | 0% | no data | |||
950 | US$4.6k | 0% | no data | |||
848 | US$4.1k | 4,890% | no data | |||
800 | US$3.9k | -46.7% | no data |